TSolution One Surgical Robot Hits Milestone in Korea TKA Cases
THINK Surgical entered the South Korean market and completed >10 total knee arthroplasty cases with the TSolution One® surgical robot. Sep 28, 2017
HD LifeSciences Launches NanoHive Lumbar Interbodies
HD LifeSciences received FDA 510(k) clearance and commenced U.S. launch of NanoHive™, a system of interbody devices for ALIF, PLIF and TLIF procedures. Sep 27, 2017
Providence Medical Receives FDA Clearance for ALLY Posterior Fixation
Providence Medical Technology received FDA 510(k) clearance to market the ALLY™ Posterior Fixation system as an adjunct to fusion in the cervical spine. Sep 27, 2017
OrthAlign Raises $10MM in Series D
OrthAlign raised US $10MM in a Series D financing round, to support development of partial knee and total hip applications for orthopaedic surgical navigation, commercialization activities, etc. Sep 27, 2017
BCBS Issues Positive Coverage Policy for coflex Interlaminar Stabilization
Paradigm Spine announced issuance of a Blue Cross Blue Shield of Michigan Medical Policy that brings coverage of the coflex® Interlaminar Stabilization® procedure to 8.6 million lives in the state. Sep 26, 2017
VirtaMed Debuts ArthroS Virtual Reality Ankle Arthroscopy Simulator
VirtaMed introduced Arthro's Ankle, reportedly the world’s first high-fidelity simulator for ankle arthroscopy. The system will launch in late 4Q17. Sep 26, 2017
SeaSpine Launches Shoreline Anterior Cervical Standalone System
SeaSpine commenced full commercial launch of Shoreline®, its anterior cervical standalone system. Sep 26, 2017
Stryker Serrato Pedicle Screws Reach 100 Surgeon Users
Stryker’s Serrato™ Pedicle Screws have been implanted by >100 U.S. surgeons during the first 30 days of initial launch. Sep 26, 2017
Mortise Medical Receives FDA Clearance for LigaMetrics Suture Anchor
Mortise Medical received FDA 510(k) clearance to market the LigaMetrics™ Suture Anchor for ankle injury repair. Sep 26, 2017
DiscGenics Raises $14 Million for Injectable Cell Therapy
DiscGenics closed a US $14MM Series B financing. Funds will support regulatory approvals and manufacturing ramp-up for Phase III clinical and commercial production of its cell therapy for treatment of degenerative disc disease. Sep 26, 2017
